This study discovered that a signaling protein called CRCR3 attracts CD8+ T cells, which are a type of white blood cell which kill virus-infected cells but could lead to lung damage during a flu infection. This is important because it can lead to new treatments for severe influenza while reducing lung damage and accelerating recovery. Co-author Jintao Xu, PhD was funded by a Catalyst Award for his work on developing immune-based treatment for fungal diseases.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.